GLPBio

Ferroptosis

Ferroptosis is a unique iron-dependent form of nonapoptotic cell death. It is triggered by oncogenic RAS-selective lethal small molecule erastin. Acitvation of ferroptosis lead to nonapoptotic destruction of cancer cells.

Products Related to Ferroptosis(211)

  • GC15541 structure
    GC15541Fluvastatin Sodium
    CAS: 93957-55-2
    Purity: >98.00%

    An HMG-CoA reductase inhibitor

  • GC15681 structure
    GC15681Liproxstatin-1
    CAS: 950455-15-9
    Purity: >98.00%

    Liproxstatin-1 is a highly efficient and selective ferroptosis inhibitor with an IC 50 of 22nM.

  • GC15972 structure
    GC15972Idebenone
    CAS: 58186-27-9
    Purity: >99.50%

    synthetic analog of coenzyme Q10 (CoQ10)

  • GC16014 structure
    GC16014Zileuton
    CAS: 111406-87-2
    Purity: >99.00%

    Zileuton, a benzothiophene N-hydroxyurea, is an oral inhibitor of 5-Lipoxygenase.

  • GC16444 structure
    GC16444Rosiglitazone
    CAS: 122320-73-4
    Purity: >98.00%

    Rosiglitazone is an orally active peroxisome proliferator-activated receptor gamma (PPARγ) selective agonist that selectively activates chimeras containing the PPARγ ligand-binding domain (LBD) but not PPARα and PPARδ with an EC 50 of 60 nM and a K d of 40nM.

  • GC16517 structure
    GC16517Eugenol
    CAS: 97-53-0
    Purity: >98.00%

    naturally occuring scent chemical

  • GC16630 structure
    GC16630Erastin
    CAS: 571203-78-6
    Purity: >98.00%

    Erastin is a ferroptosis activator.

  • GC16733 structure
    GC16733Vildagliptin (LAF-237)
    CAS: 274901-16-5
    Purity: >98.00%

    A DPP-4 inhibitor

  • GC16868 structure
    GC16868Sulfasalazine
    CAS: 599-79-1
    Purity: >98.00%

    Sulfasalazine is a sulfonamide drug.

  • GC17309 structure
    GC17309Withaferin A
    CAS: 5119-48-2
    Purity: >98.00%

    Withaferin A is a steroidal lactone generally obtained from Withania somnifera (L.) Dunal, commonly known as Ashwagandha.

  • GC17369 structure
    GC17369Sorafenib
    CAS: 284461-73-0
    Purity: >98.00%

    Sorafenib acts as a multi-kinase inhibitor, targeting Raf-1 and B-Raf with IC 50 values of 6 nM and 22 nM, respectively.

  • GC17412 structure
    GC17412Deferasirox Fe3+ chelate
    CAS: 554435-83-5
    Purity: >98.00%
  • GC17498 structure
    GC17498L-Glutamine
    CAS: 56-85-9
    Purity: >98.00%

    Non-essential amino acid

  • GC18089 structure
    GC18089Nordihydroguaiaretic acid
    CAS: 500-38-9
    Purity: >97.00%

    Nordihydroguaiaretic acid is a potent 5-lipoxygenase (5-LOX) inhibitor with an IC 50 value of 8μM.

  • GC18101 structure
    GC18101Deferiprone
    CAS: 30652-11-0
    Purity: >98.00%

    Chelating agent

  • GC18705 structure
    GC18705ML-210
    CAS: 1360705-96-9
    Purity: >98.00%

    ML-210 is a prodrug that selectively inhibits GPX4 covalently with an EC 50 of 30nM.

  • GC19254 structure
    GC19254ML385
    CAS: 846557-71-9
    Purity: >98.00%

    ML385 is a cell-active NRF2 inhibitor (IC 50 =1.9μM).

  • GC19457 structure
    GC19457Trolox
    CAS: 53188-07-1
    Purity: >98.00%

    Trolox is a cell-permeable, water-soluble derivative of vitamin E with potent antioxidant properties.

  • GC19706 structure
    GC19706Propacetamol hydrochloride
    CAS: 66532-86-3
    Purity: >98%
  • GC19936 structure
    GC19936Quisinostat dihydrochloride
    CAS: 875320-31-3
    Purity: >98%

    Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity.

  • GC20109 structure
    GC20109Cefotiam hexetil hydrochloride
    CAS: 95789-30-3
    Purity: >98%

    Cefotiam hexetil hydrochloride (CTM-HE) is an oral third-generation cephalosporin, which is a prodrug of cefotiam, but has no anti-bacterial property. Cefotiam is an antibiotic.

  • GC26219 structure
    GC26219NCOA4 - 9a
    CAS: 2650557-72-3
    Purity: >98.00%

    NCOA4 - 9a is an inhibitor of ferritinophagy that inhibits erastin-induced ferroptosis, with an EC 50 value of 0.29μM.

  • GC30039 structure
    GC30039FIN56
    CAS: 1083162-61-1
    Purity: >98.00%

    FIN56, a novel ferroptosis inducer, triggers ferroptosis by increasing the degradation of GPX4 .

  • GC30067 structure
    GC30067Butylhydroxyanisole (Butylated hydroxyanisole)
    CAS: 25013-16-5
    Purity: >99.00%

    Butylhydroxyanisole (Butylated hydroxyanisole) (Butylated hydroxyanisole) is an antioxidant used as a food additive preservative.